{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:52:58Z","timestamp":1794711178632,"version":"4.9.1"},"reference-count":70,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,10,6]]},"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Hypertensive disorders of pregnancy (HDP) affect one in ten pregnancies and often persist postpartum when complications can occur. We aimed to determine the effectiveness and safety of pharmacological interventions, other interventions and different care models for postpartum hypertension management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A systematic review was undertaken. Nine electronic databases, including Medline, were searched from inception to 16 March 2017. After duplicate removal, 4561 records were screened. Two authors independently selected studies, extracted study characteristics and data, and assessed methodological quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Randomised controlled trials, case\u2013control studies and cohort studies from any country and healthcare setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Postnatal women with HDP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Therapeutic intervention for management of hypertension, compared with another intervention, placebo or no intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Outcome data were collected for maternal mortality and severe morbidity; systolic, diastolic and mean arterial blood pressure (BP) control; and safety data. Secondary outcome data collected included the length of postnatal hospital stay and laboratory values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>39 studies were included (n=2901). Results were heterogeneous in terms of intervention, comparison and outcome requiring a narrative approach. There were insufficient data to recommend any single pharmacological intervention. 18 studies reported calcium-channel blockers, vasodilators and beta-blockers lowered BP postpartum. 12 of these reported safety data. Limited data existed regarding management in the weeks following hospital discharge. Neither loop diuretics (three studies) nor corticosteroids (one study) produced clinical benefit. Uterine curettage significantly reduced BP over the first 48\u2009hours postpartum (range 6\u201313\u2009mm Hg) compared with standard care (eight studies), with safety data only reported by four of eight studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There was insufficient evidence to recommend a particular BP threshold, agent or model of care, but three classes of antihypertensive appeared variably effective. Further comparative research, including robust safety data, is required. Curettage reduced BP, but without adequate reporting of harms, so it cannot currently be recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-018696","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T01:40:27Z","timestamp":1511919627000},"page":"e018696","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":75,"title":["Postpartum management of hypertensive disorders of pregnancy: a systematic review"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6989-0887","authenticated-orcid":false,"given":"Alexandra E","family":"Cairns","sequence":"first","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Pealing","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M N","family":"Duffy","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nia","family":"Roberts","sequence":"additional","affiliation":[{"name":"Knowledge Centre, Bodleian Libraries, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L","family":"Tucker","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Leeson","sequence":"additional","affiliation":[{"name":"Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy H","family":"MacKillop","sequence":"additional","affiliation":[{"name":"Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3638-028X","authenticated-orcid":false,"given":"Richard J","family":"McManus","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,11,28]]},"reference":[{"key":"2025121511094184000_7.11.e018696.1","doi-asserted-by":"publisher","DOI":"10.3109\/10641950902777747"},{"key":"2025121511094184000_7.11.e018696.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.015721"},{"key":"2025121511094184000_7.11.e018696.3","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.123824"},{"key":"2025121511094184000_7.11.e018696.4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1600-0412.2011.01218.x","article-title":"Maternal and obstetric factors associated with delayed postpartum eclampsia: a national study population","volume":"90","author":"Kayem","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2025121511094184000_7.11.e018696.5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/00007611-198312000-00008","article-title":"Late postpartum eclampsia: an update","volume":"76","author":"Watson","year":"1983","journal-title":"South Med J"},{"key":"2025121511094184000_7.11.e018696.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000151116.84113.56"},{"key":"2025121511094184000_7.11.e018696.7","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181c14e3e"},{"key":"2025121511094184000_7.11.e018696.8","unstructured":"National Institute for Health and Care Excellence. NICE clinical guideline 107: hypertension in pregnancy: the management of hypertensive disorders during pregnancy, 2011."},{"key":"2025121511094184000_7.11.e018696.9","unstructured":"ACOG Task Force on Hypertension in Pregnancy. Hypertension in pregnancy: American college of obstetricians and gynecologists, 2013."},{"key":"2025121511094184000_7.11.e018696.10","doi-asserted-by":"crossref","unstructured":"Magee L , von Dadelszen P . Prevention and treatment of postpartum hypertension. Cochrane Database Syst Rev 2013;4.","DOI":"10.1002\/14651858.CD004351.pub3"},{"key":"2025121511094184000_7.11.e018696.11","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"2025121511094184000_7.11.e018696.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7172.1562"},{"key":"2025121511094184000_7.11.e018696.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"2025121511094184000_7.11.e018696.14","unstructured":"Wells GA , Shea B , O\u2019Connell D , et al . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2017 http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm (accessed 14 Jul 2017)."},{"key":"2025121511094184000_7.11.e018696.15","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00404-013-2866-0","article-title":"Does immediate postpartum curettage of the endometrium accelerate recovery from preeclampsia-eclampsia? A randomized controlled trial","volume":"288","author":"Ragab","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"2025121511094184000_7.11.e018696.16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.AOG.0000148270.53433.66","article-title":"Postpartum preeclampsia management with furosemide: a randomized clinical trial","volume":"105","author":"Ascarelli","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.17","first-page":"1","article-title":"Management of hypertensive emergencies of pregnancy by hydralazine bolus injection vs continuous drip\u2013a comparative study","volume":"7","author":"Begum","year":"2002","journal-title":"Medscape Womens Health"},{"key":"2025121511094184000_7.11.e018696.18","first-page":"E191","article-title":"Role of postpartum curettage in recovery of severe preeclampsia and eclampsia patients-a randomised controlled trial","volume":"131","author":"Mallapur","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"2025121511094184000_7.11.e018696.19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/10641955.2016.1239735","article-title":"Furosemide in postpartum management of severe preeclampsia: a randomized controlled trial","volume":"36","author":"Veena","year":"2017","journal-title":"Hypertens Pregnancy"},{"key":"2025121511094184000_7.11.e018696.20","unstructured":"United Nations Department of Economic and Social Affairs. World economic situation and prospects. New York, United States of America: United Nations, 2016."},{"key":"2025121511094184000_7.11.e018696.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70314-5"},{"key":"2025121511094184000_7.11.e018696.22","first-page":"328","article-title":"A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy","volume":"70","author":"Mabie","year":"1987","journal-title":"Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1479-828X.2007.00738.x","article-title":"A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial","volume":"47","author":"Hennessy","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2025121511094184000_7.11.e018696.24","first-page":"371","article-title":"Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy","volume":"1","author":"Garden","year":"1982","journal-title":"Clin Exp Hypertens B"},{"key":"2025121511094184000_7.11.e018696.25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht308.P1426"},{"key":"2025121511094184000_7.11.e018696.26","doi-asserted-by":"publisher","DOI":"10.1097\/00006199-199709000-00003"},{"key":"2025121511094184000_7.11.e018696.27","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.ajog.2015.10.064","article-title":"40: Oral labetalol compared to oral extended release nifedipine for persistent postpartum hypertension: a randomized controlled trial","volume":"214","author":"Sharma","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/10641955.2016.1231317","article-title":"Oral labetalol compared to oral nifedipine for postpartum hypertension: a randomized controlled trial","volume":"36","author":"Sharma","year":"2017","journal-title":"Hypertens Pregnancy"},{"key":"2025121511094184000_7.11.e018696.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168124","article-title":"Clonidine versus captopril for severe postpartum hypertension: a randomized controlled trial","volume":"12","author":"Noronha Neto C","year":"2017","journal-title":"PLoS One"},{"key":"2025121511094184000_7.11.e018696.30","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1097\/01.AOG.0000463056.75838.b3","article-title":"Clonidine compared with captopril for severepostpartum hypertension","volume":"125","author":"Amorim","year":"2015","journal-title":"Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.preghy.2014.10.061","article-title":"Clonidine versus captopril for severe postpartum hypertension: a randomized controlled trial","volume":"5","author":"Katz","year":"2015","journal-title":"Pregnancy Hypertens"},{"key":"2025121511094184000_7.11.e018696.32","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0002-9378(90)91011-Z","article-title":"The use of nifedipine during the postpartum period in patients with severe preeclampsia","volume":"162","author":"Barton","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.33","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1097\/01.AOG.0000447316.97709.bd","article-title":"Does the addition of a specialized postpartum clinic improvethe care of women with preeclampsia?","volume":"123","author":"Bibbo","year":"2014","journal-title":"Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.34","first-page":"118","article-title":"Efficacy of alpha-methyldopa and nifedipine in the treatment of postpartum hypertension. [Turkish] Postpartum hipertansiyon tedavisinde alfametildopa ve nifedipinin etkinligi","volume":"6","author":"Sayin","year":"2005","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"2025121511094184000_7.11.e018696.35","doi-asserted-by":"publisher","DOI":"10.1080\/10641950701204430"},{"key":"2025121511094184000_7.11.e018696.36","first-page":"173","article-title":"Arterial hypertensions of labor and the post-partum period. [French] Les Hypertensions Arterielles Du Travail Et Du Post-Partum","volume":"74","author":"Palot","year":"1979","journal-title":"Rev Fr Gynecol Obstet"},{"key":"2025121511094184000_7.11.e018696.37","first-page":"S120","article-title":"Control of cardiovascular risk factors with ursodeoxycholic acid and indapamide in postpreeclamptic nursing mothers: Results from a randomized, case-control 1-year study","volume":"21","author":"Ilshat Gaisin","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"2025121511094184000_7.11.e018696.38","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-999634"},{"key":"2025121511094184000_7.11.e018696.39","first-page":"431","article-title":"Early puerperal hypertension management: hydralazine vs methyldopa","volume":"8","author":"Martin","year":"1988","journal-title":"Clin Exp Hypertens B"},{"key":"2025121511094184000_7.11.e018696.40","first-page":"207","article-title":"[Management of severe pre-eclampsia in the puerperium. Comparative study of sublingual nifedipine and hydralazine]","volume":"59","author":"Walss Rodr\u00edguez","year":"1991","journal-title":"Ginecol Obstet Mex"},{"key":"2025121511094184000_7.11.e018696.41","first-page":"S378","article-title":"718: Peripartum anti-hypertensive choice affects time to blood pressure control in treating hypertensive disorders of\u00a0pregnancy","volume":"214","author":"Shumard","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.42","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1471-0528.1982.tb04659.x","article-title":"A randomized study comparing timolol and methyldopa in hospital treatment of puerperal hypertension","volume":"89","author":"Fidler","year":"1982","journal-title":"Br J Obstet Gynaecol"},{"key":"2025121511094184000_7.11.e018696.43","first-page":"255","article-title":"[Experience with serpasil and luminal in the management of pregnancy-and puerperal toxemias]","volume":"141","author":"Krebs","year":"1956","journal-title":"Gynaecologia"},{"key":"2025121511094184000_7.11.e018696.44","first-page":"410","article-title":"[Tests of reserpine and phenobarbital in therapy of toxicosis of pregnancy and puerperium]","volume":"16","author":"Krebs","year":"1956","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"2025121511094184000_7.11.e018696.45","first-page":"E195","article-title":"Postpartum furosemide for accelerating recovery in women with severe preeclampsia: A randomized clinical trial","volume":"131","author":"Amorim","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"2025121511094184000_7.11.e018696.46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/01443619750114040","article-title":"A randomised placebo controlled trial of loop diuretics in moderate\/severe pre-eclampsia, following delivery","volume":"17","author":"Matthews","year":"1997","journal-title":"J Obstet Gynaecol"},{"key":"2025121511094184000_7.11.e018696.47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.preghy.2014.10.297","article-title":"Use of carperitide for postpartum diuresis of severe preeclampsia","volume":"5","author":"Shigemitsu","year":"2015","journal-title":"Pregnancy Hypertens"},{"key":"2025121511094184000_7.11.e018696.48","first-page":"195","article-title":"5HT) receptor blockade in puerperal pre-eclampsia","volume":"1","author":"Weiner","year":"1982","journal-title":"Clin Exp Hypertens B"},{"key":"2025121511094184000_7.11.e018696.49","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0002-9378(84)90023-1","article-title":"Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist","volume":"149","author":"Weiner","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0002-9378(85)90095-X","article-title":"The effect of serotonergic blockade in postpartum preeclamptic patients","volume":"153","author":"Montenegro","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.51","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.AOG.0000207637.01824.fe","article-title":"Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial","volume":"107","author":"Hladunewich","year":"2006","journal-title":"Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.52","first-page":"222","article-title":"[Treatment of albuminuria in gestational hypertension puerpera in the severe preeclampeia stage by TCM therapy for stasis-removing and diuresis]","volume":"29","author":"Liu","year":"2009","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"2025121511094184000_7.11.e018696.53","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000154887.57440.d1"},{"key":"2025121511094184000_7.11.e018696.54","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ajog.2003.10.106","article-title":"Adjunctive intravenous dexamethasone in patients with severe preeclampsia not complicated by HELLP syndrome","volume":"189","author":"Barrilleaux","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/OGX.0000000000000040","article-title":"Editorial Comment: Does Immediate Postpartum Curettage of the Endometrium Accelerate Recovery From Preeclampsia\u2013Eclampsia? A Randomized Controlled Trial","volume":"69","author":"Caughey","year":"2014","journal-title":"Obstet Gynecol Surv"},{"key":"2025121511094184000_7.11.e018696.56","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0002-9378(15)33435-9","article-title":"Amelioration of the hypertension of toxemia by postpartum curettage","volume":"81","author":"HUNTER","year":"1961","journal-title":"Am J Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.57","first-page":"24","article-title":"The effect of postpartum curettage in severe preeclampsia and eclampsia in recovery (A\u011f\u0131r preeklamps\u0131 ve eklampsi in iyile\u015fmesinde postpartum kuretajin etkisi)","volume":"4","author":"Gocmen","year":"1996","journal-title":"Perinatoloji Dergisi"},{"key":"2025121511094184000_7.11.e018696.58","first-page":"275","article-title":"[\u201cPostpartum curettage in severe toxemia with and without premature loosening of the placenta\u201d]","volume":"26","author":"Salvatore","year":"1967","journal-title":"Matern Infanc"},{"key":"2025121511094184000_7.11.e018696.59","first-page":"502","article-title":"Immediate postpartum curettage: accelerated recovery from severe preeclampsia","volume":"81","author":"Magann","year":"1993","journal-title":"Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/107155769400100306","article-title":"Accelerated recovery from severe preeclampsia: uterine curettage versus nifedipine","volume":"1","author":"Magann","year":"1994","journal-title":"J Soc Gynecol Investig"},{"key":"2025121511094184000_7.11.e018696.61","first-page":"111S","article-title":"Immediate postpartum curettage accelerates clinical recovery in severe preeclampsia","volume":"105","author":"Gomez","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.62","first-page":"55","article-title":"Effects of postpartum uterine curettage on maternal well-being in severe preeclamptic patients","volume":"33","author":"Alkan","year":"2006","journal-title":"Clin Exp Obstet Gynecol"},{"key":"2025121511094184000_7.11.e018696.63","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199627003-00007"},{"key":"2025121511094184000_7.11.e018696.64","unstructured":"Committee JF . British National Formulary (BNF). 71st edn. BMJ Publishing Group Ltd and Royal Pharmaceutical Society, 2016."},{"key":"2025121511094184000_7.11.e018696.65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2002.01012.x"},{"key":"2025121511094184000_7.11.e018696.66","doi-asserted-by":"crossref","unstructured":"Duley L , Gulmezoglu AM , Henderson-Smart DJ , et al . Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2010;11.","DOI":"10.1002\/14651858.CD000025.pub2"},{"key":"2025121511094184000_7.11.e018696.67","first-page":"MR000005","article-title":"Full publication of results initially presented in abstracts","volume":"2","author":"Scherer","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121511094184000_7.11.e018696.68","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/1471-0528.12929","article-title":"The CROWN Initiative: journal editors invite researchers to develop core outcomes in women\u2019s health","volume":"121","author":"Khan","year":"2014","journal-title":"Br J Obstet Gynaecol"},{"key":"2025121511094184000_7.11.e018696.69","doi-asserted-by":"crossref","unstructured":"Abalos E , Duley L , Steyn DW . Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2014;2.","DOI":"10.1002\/14651858.CD002252.pub3"},{"key":"2025121511094184000_7.11.e018696.70","unstructured":"National Institute for Health and Care Excellence. NICE clinical guideline 127: hypertension in adults: diagnosis and management, 2011."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-018696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:09:52Z","timestamp":1765825792000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-018696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":70,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,28]]},"published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1136\/bmjopen-2017-018696"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-018696","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2017-018696.supp1","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2017-018696.supp2","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2017-018696.supp3","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2017-018696.supp4","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2017-018696.supp5","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2017-018696.supp6","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}